alnylam pharmaceuticals inc
Muthiah Manoharan Ph.D.
Senior Vice President of Drug Discovery, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Muthiah Manoharan PhD serves as Senior Vice President of Drug Discovery at Alnylam Pharmaceuticals Inc. Previously, Dr. Manoharan served as Vice President of Drug Discovery at Alnylam Pharmaceuticals Inc. since joining in February 2003. From January 2001 to January 2003, Dr. Manoharan served as the Executive Director of Medicinal Chemistry at Isis Pharmaceuticals Inc., a biotechnology company focused on antisense oligonucleotide therapeutics. He also served as a Director ...
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
University Of North Carolina At Chapel Hill
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|